SCHEMBL30890782

SCHEMBL30890782

[2H]C1N(CCCC)[C@@H](C)CC12Oc1ncc(C)cc1NC2=O

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PDE1A P54750 3/20 0.33
▸ PDE1B Q01064 3/20 0.33
▸ PDE4D Q08499 3/20 0.33
▸ PDE1C Q14123 3/20 0.33
▸ OTUD7B Q6GQQ9 11/20 0.32
▸ PDE6A P16499 1/20 0.32
▸ PDE6B P35913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890761 0.76 GAA (0.39) —
SCHEMBL22695464 0.72 OTUD7B (0.44) OTUD7B
SCHEMBL24306294 0.71 OTUD7B (0.34) OTUD7B
SCHEMBL30890558 0.71 OTUD7B (0.43) OTUD7B
SCHEMBL24307027 0.70 OTUD7B (0.42) OTUD7B
SCHEMBL30890516 0.66 OTUD7B (0.39) OTUD7B
SCHEMBL21352872 0.57 OTUD7B (0.44) OTUD7B
SCHEMBL22803136 0.57 OTUD7B (0.41) OTUD7B
SCHEMBL1190598 0.56 MMP12 (0.53) —
SCHEMBL25092977 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback